Marlene V. Strege
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marlene V. Strege has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Greg J. Siegle
Department of Psychiatry, University of Pittsburgh, Pittsburgh, USA
5 shared publications Greg J. Siegle
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
4 shared publicationsJohn A. Richey
Department of Psychology, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
3 shared publicationsGia Canovali
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Hospital, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA
2 shared publications- Kymberly D. Young
Department of Psychiatry, University of Pittsburgh School of Medicine
2 shared publications Kymberly Young
Department of Psychiatry, University of Pittsburgh, Pittsburgh, United States
2 shared publications
Latest Publications
- 13 October 2025
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 50 (1) , 241-253
Ruminative Thought Content Changes by Year: A Computational Linguistic Analysis
- 13 October 2025
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 50 (1) , 241-253
Ruminative Thought Content Changes by Year: A Computational Linguistic Analysis
- Open Access
- 15 March 2024
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 176, 104523
Amygdala real-time fMRI neurofeedback upregulation in treatment resistant depression: Proof of concept and dose determination
- 15 March 2024
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 176, 104523
Open AccessAmygdala real-time fMRI neurofeedback upregulation in treatment resistant depression: Proof of concept and dose determination
- 16 July 2023
- Published by Elsevier in Journal of Affective Disorders
- Vol. 339, 495-501
Enhanced efficacy of CBT following augmentation with amygdala rtfMRI neurofeedback in depression
- 16 July 2023
- Published by Elsevier in Journal of Affective Disorders
- Vol. 339, 495-501
Enhanced efficacy of CBT following augmentation with amygdala rtfMRI neurofeedback in depression
- 16 May 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (1) , 136-147
Trying to name what doesn't change: Neural nonresponse to Cognitive Therapy for depression
Background: Theoretical models of neural mechanisms underlying Cognitive Behavior Therapy (CBT) for major depressive disorder (MDD) propose that psychotherapy changes neural functioning of prefrontal cortical structures associated with cognitive-control processes (DeRubeis, Siegle, & Hollon, 2008); however, MDD is persistent and characterized by long-lasting vulnerabilities to recurrence after intervention, suggesting that underlying neural mechanisms of MDD remain despite treatment. It follows that identification of treatment-resistant aberrant neural processes in MDD may inform clinical and research efforts targeting sustained remission. Thus, we sought to identify brain regions showing aberrant neural functioning in MDD that either (1) fail to exhibit substantive change (nonresponse) or (2) exhibit functional changes (response) following CBT.Methods: To identify treatment-resistant neural processes (as well as neural processes exhibiting change after treatment), we collected functional magnetic resonance imaging (fMRI) data of MDD patients (n = 58) before and after CBT as well as never-depressed controls (n = 35) before and after a similar amount of time. We evaluated fMRI data using conjunction analyses, which utilized several contrast-based criteria to characterize brain regions showing both differences between patients and controls at baseline and nonresponse or response to CBT.Results: Findings revealed nonresponse in a cerebellar region and response in prefrontal and parietal regions.Conclusions: Results are consistent with prior theoretical models of CBT's direct effect on cortical regulatory processes but expand on them with identification of additional regions (and associated neural systems) of response and nonresponse to CBT.
- 16 May 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (1) , 136-147
Trying to name what doesn't change: Neural nonresponse to Cognitive Therapy for depression
Background: Theoretical models of neural mechanisms underlying Cognitive Behavior Therapy (CBT) for major depressive disorder (MDD) propose that psychotherapy changes neural functioning of prefrontal cortical structures associated with cognitive-control processes (DeRubeis, Siegle, & Hollon, 2008); however, MDD is persistent and characterized by long-lasting vulnerabilities to recurrence after intervention, suggesting that underlying neural mechanisms of MDD remain despite treatment. It follows that identification of treatment-resistant aberrant neural processes in MDD may inform clinical and research efforts targeting sustained remission. Thus, we sought to identify brain regions showing aberrant neural functioning in MDD that either (1) fail to exhibit substantive change (nonresponse) or (2) exhibit functional changes (response) following CBT.Methods: To identify treatment-resistant neural processes (as well as neural processes exhibiting change after treatment), we collected functional magnetic resonance imaging (fMRI) data of MDD patients (n = 58) before and after CBT as well as never-depressed controls (n = 35) before and after a similar amount of time. We evaluated fMRI data using conjunction analyses, which utilized several contrast-based criteria to characterize brain regions showing both differences between patients and controls at baseline and nonresponse or response to CBT.Results: Findings revealed nonresponse in a cerebellar region and response in prefrontal and parietal regions.Conclusions: Results are consistent with prior theoretical models of CBT's direct effect on cortical regulatory processes but expand on them with identification of additional regions (and associated neural systems) of response and nonresponse to CBT.
- 9 January 2023
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 17 (4) , 450-460
Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application
We sought to identify baseline (pre-treatment) neural markers associated with treatment response in major depressive disorder (MDD), specific to treatment type, Cognitive Behavioral Therapy (CBT) or pharmacotherapy (selective serotonin reuptake inhibitors; SSRI). We conducted a meta-analysis of functional magnetic resonance imaging (fMRI) studies to identify neural prognostic indicators of response to CBT or SSRI. To verify the regions derived from literature, the meta-analytic regions were used to predict clinical change in a verification sample of participants with MDD who received either CBT (n = 60) or an SSRI (n = 19) as part of prior clinical trials. The meta-analysis consisted of 21 fMRI studies that used emotion-related tasks. It yielded prognostic regions of the perigenual (meta pgACC) and subgenual anterior cingulate cortex (meta sgACC), associated with SSRI and CBT response, respectively. When applying the meta-analytic regions to predict treatment response in the verification sample, reactivity of the meta pgACC was prognostic for SSRI response, yet the effect direction was opposite of most prior studies. Meta sgACC reactivity failed to be prognostic for CBT response. Results confirm the prognostic potential of neural reactivity of ACC subregions in MDD but further research is necessary for clinical translation.
- 9 January 2023
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 17 (4) , 450-460
Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application
We sought to identify baseline (pre-treatment) neural markers associated with treatment response in major depressive disorder (MDD), specific to treatment type, Cognitive Behavioral Therapy (CBT) or pharmacotherapy (selective serotonin reuptake inhibitors; SSRI). We conducted a meta-analysis of functional magnetic resonance imaging (fMRI) studies to identify neural prognostic indicators of response to CBT or SSRI. To verify the regions derived from literature, the meta-analytic regions were used to predict clinical change in a verification sample of participants with MDD who received either CBT (n = 60) or an SSRI (n = 19) as part of prior clinical trials. The meta-analysis consisted of 21 fMRI studies that used emotion-related tasks. It yielded prognostic regions of the perigenual (meta pgACC) and subgenual anterior cingulate cortex (meta sgACC), associated with SSRI and CBT response, respectively. When applying the meta-analytic regions to predict treatment response in the verification sample, reactivity of the meta pgACC was prognostic for SSRI response, yet the effect direction was opposite of most prior studies. Meta sgACC reactivity failed to be prognostic for CBT response. Results confirm the prognostic potential of neural reactivity of ACC subregions in MDD but further research is necessary for clinical translation.
- 24 August 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 317, 228-235
What does “staying well” after depression mean? Chronic low grade symptomatology after treatment for depression is common
- 24 August 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 317, 228-235
What does “staying well” after depression mean? Chronic low grade symptomatology after treatment for depression is common
- 1 October 2021
- Vol. 44 (7) , 326-334
Integrating Neuroscience Into Clinical Practice: Current Opinions and Dialogue Between Drs. Jacqueline Persons and Kerry Ressler.
- 1 October 2021
- Vol. 44 (7) , 326-334
Integrating Neuroscience Into Clinical Practice: Current Opinions and Dialogue Between Drs. Jacqueline Persons and Kerry Ressler.
- Open Access
Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Theory, meta-analysis, and empirical application
Objective In the interest of precision medicine, we sought to derive preclinical markers of neural mechanisms associated with treatment response in unipolar depression, separated by treatment type. Methods We conducted separate neuroimaging meta-analyses of neural predictors for response to Cognitive Behavioral Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs). We assessed whether reactivity of derived regions predicted clinical change in a preference trial of patients with major depressive disorder (MDD) who received CBT (n = 61) or SSRIs (n = 19). Results The meta-analyses yielded regions within the perigenual (pgACC) and subgenual anterior cingulate cortex (sgACC) associated with SSRI and CBT response, respectively. In our sample, reactivity of the sgACC region was prognostic for response to CBT, but neither cingulate region was prognostic for response to SSRIs using a linguistic task; most prognostic SSRI studies used images. An exploratory analysis revealed a pgACC region for which reactivity to images was prognostic for response to SSRIs. Conclusions Results suggest that neural reactivity of the sgACC and pgACC are associated with CBT and SSRI response for unipolar depression. Further research incorporating methodological considerations is necessary for translation.
Open AccessCingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Theory, meta-analysis, and empirical application
Objective In the interest of precision medicine, we sought to derive preclinical markers of neural mechanisms associated with treatment response in unipolar depression, separated by treatment type. Methods We conducted separate neuroimaging meta-analyses of neural predictors for response to Cognitive Behavioral Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs). We assessed whether reactivity of derived regions predicted clinical change in a preference trial of patients with major depressive disorder (MDD) who received CBT (n = 61) or SSRIs (n = 19). Results The meta-analyses yielded regions within the perigenual (pgACC) and subgenual anterior cingulate cortex (sgACC) associated with SSRI and CBT response, respectively. In our sample, reactivity of the sgACC region was prognostic for response to CBT, but neither cingulate region was prognostic for response to SSRIs using a linguistic task; most prognostic SSRI studies used images. An exploratory analysis revealed a pgACC region for which reactivity to images was prognostic for response to SSRIs. Conclusions Results suggest that neural reactivity of the sgACC and pgACC are associated with CBT and SSRI response for unipolar depression. Further research incorporating methodological considerations is necessary for translation.
- 18 December 2018
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 49 (16) , 2681-2691
Where are the breaks in translation from theory to clinical practice (and back) in addressing depression? An empirical graph-theoretic approach
BackgroundResearch in depression has progressed rapidly over the past four decades. Yet depression rates are not subsiding and treatment success is not improving. We examine the extent to which the gap between science and practice is associated with the level of integration in how depression is considered in research and stakeholder-relevant documents.MethodsWe used a network-science perspective to analyze similar uses of depression relevant terms in the Google News corpus (approximately 1 billion words) and the Web of Science database (120 000 documents).ResultsThese analyses yielded consistent pictures of insular modules associated with: (1) patient/providers, (2) academics, and (3) industry. Within academia insular modules associated with psychology, general medical, and psychiatry/neuroscience/biology were also detected.ConclusionsThese analyses suggest that the domain of depression is fragmented, and that advancements of relevance to one stakeholder group (academics, industry, or patients) may not translate to the others. We consider potential causes and associated responses to this fragmentation that could help to unify and advance translation from research on depression to the clinic, largely involving harmonizing employed language, bridging conceptual domains, and increasing communication across stakeholder groups.
- 18 December 2018
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 49 (16) , 2681-2691
Where are the breaks in translation from theory to clinical practice (and back) in addressing depression? An empirical graph-theoretic approach
BackgroundResearch in depression has progressed rapidly over the past four decades. Yet depression rates are not subsiding and treatment success is not improving. We examine the extent to which the gap between science and practice is associated with the level of integration in how depression is considered in research and stakeholder-relevant documents.MethodsWe used a network-science perspective to analyze similar uses of depression relevant terms in the Google News corpus (approximately 1 billion words) and the Web of Science database (120 000 documents).ResultsThese analyses yielded consistent pictures of insular modules associated with: (1) patient/providers, (2) academics, and (3) industry. Within academia insular modules associated with psychology, general medical, and psychiatry/neuroscience/biology were also detected.ConclusionsThese analyses suggest that the domain of depression is fragmented, and that advancements of relevance to one stakeholder group (academics, industry, or patients) may not translate to the others. We consider potential causes and associated responses to this fragmentation that could help to unify and advance translation from research on depression to the clinic, largely involving harmonizing employed language, bridging conceptual domains, and increasing communication across stakeholder groups.